Here, a reduced ADAR2 activity decreased the editing ratio at the Q/R site in subunit 2 of the ionotropic AMPA glutamate receptor (GRIA2, also known as GluA2 and GluR-B) transcript, which was shown to be associated with tumor progression [14]. Here, GRIA2 is linked to neoplasm.